Vol.
133,
No. 2, 1985
December
17,
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
1985
Pages
SYNTHESIS AND --IN VITRO HORMONE-DIPHTHERIA TOXIN Thomas
N.
ACTIVITY FRAGMENT
430-435
OF A A HYBRID
Oeltmann
Department of Medicine Vanderbilt School of Medicine Nashville, TN 37232 Received
October
25,
1985
The synthesis and in vitro biological activity of intact human chorionicgonadotropin and fragment disulfide conjugate is reported. This hybrid retained of uncoupled hCG and was shown to be specifically tumor which binds hCG while being non-toxic towards for hCG. 0 1985 Academic Press, Inc.
During
the
toxins”. or
past
The
term
polyclonal, on
amodel
system
tropin-diphtheria activity
Since
the
hCG
currently
thus
as
have many fail
to
into
the
cytoplasm
Abbreviations NaCl, pH 7.2); pyridyldithiopropionate; trichloroacetic
hCG
we
the
will
on be
able
intracellular with cell
the
many
where
to
tumor
this cell
to
it
can
and exert
430
continuing
we
have
developed
chorionic
gonado-
investigated
its
Leydig
cell
tumor
which
internalized,
that our
-in
tumor.
antigens is
surfaces
are efforts
such
as
acidification
the
escape
of
its
toxic
effect.
used: PBS, phosphate buffered saline SPDP, N-succinimidyl-3-(2-pyridyldithiol)-propionate; SDS, sodium dodecyl sulfate; acid; hCG, human chorionic gonadotropin.
0006-291X/85 $1.50 CopVright 0 I985 by Academic Press, Inc. All rights of reproduction in any form resewed.
our
receptor
concentrate
events lysosome,
and
unlike bound
In
mono
usingmonoclonal
a human
defined
“isxnuno-
antibody,
encountered
a well
function,
in
binding
proteins,
(hCG-DTA)
using
interest
toxin.
synthesised
toxin
and
in
a cell
wehave
protein
complexes
fusion of
problems
the
a known
subsequent
vesicle,
of
function,
internalize, of
hybrid
these
We have
antigen-antibody
investigation endocytotic
no known
to
of
A hybrid
has
refers
a hybrid protein composed A of diphtheria toxin in a >90% of the binding ability toxic to a mouse Leydig cell cells which lack receptors
increase
uptake
specific
receptor
an
bacterial
moiety.
a cell
been
a plant,or
some
fragment
vitro
to
mediated
binding
has
usually
bound
to overcome the
there
“immunotoxin”
receptor
as
unlike
years
covalently
studies
antibody
five
of
the
toxic
(10
ml4 phosphate,
CON A,
Conconavalin
shed
and
on
the
of
the
moiety
0.15 M PDP, 2A; TCA,
Vol.
133,
No. 2, 1985
BIOCHEMICAL
AND
MATERIALS
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
AND METHODS
Reagents and cell culture: Human chorionic gonadotropin (hCG) was obtained as a gift from the National Pituitary Agency, Baltimore, Maryland. N-Succiminidyl-3(Z-pyridyldithiol-propionate (SPDP) was obtained from Sigma. The M548OP Leydig tumor was obtained from the PapanicolauCancer Research Institute inMiami, Florida and was originally a gift of Dr. William Neaves of the University of Texas Health Science Center at Dallas to Dr. David Puett when he was at this institution. The tumors are maintained by serial transplantation every 2 weeks into 7-9 week old male C57 B1/6 mice by the method of Neaves (1). Single cell suspensions of tumor are prepared by the method of Ascoli and Puett (2). K562, a human erythroid precursor cell, and Molt-4, a human T cell line, were used as control cell lines. Anti-diphtheria toxin was obtained from Connaught Laboratories, Swiftwater, PA and Anti-hCG was obtained from Miles Laboratories, Inc., Elkhart, IN. All other chemicals and reagents were of the highest quality available commercially. Methods: hCG was labeled with lz51 by the Chloramine-T method of Greenwood et al (3) asmodifiedby Bellisarioand Bahl (4) for the retention of biological actigtr Protein was estimated by the ultraviolet spectrophotometric method of Waddel (5). Polyacrylamide gel electrophoresis in 0.1% sodium dodecyl sulfate was carried out by the method of Laemmil (6) as modified by O'Farrell Crude diphtheria --et al (7). toxin was obtained from Connaught Laboratories, Toronto, Canada. After purification, Fragment A was prepared as described by Chung and Collier (8). Synthesis of hCG-diphtheria toxin fragment A: hCG was coupled to fragment A by methods we have reported (9) and was originally described by Martinez St (10). Briefly, to 5mg hCG in 1 ml O.lM sodium phosphate, pH 7.2 containing 0.15 M NaCl (PBS) was added SPDP in the amounts indicated in 50 pl of absolute ethanol. The solution was allowed to stand at room temperature for 30 minutes followed by dialysis at 4°C against PBS for 18 hours. Diphtheria toxin fragment A (3-fold molar excess) was reduced with 50 mM dithiothreitol overnight, passed over a G25 Sephadex column and immediately mixed with the Z-pyridyldithiol-propionateThis mixture was incubated at room temperature for 1 hour and the hCG (PDP-hCG). resulting coupled product was isolated as described in the results section. Cellular Protein Synthesis: Protein synthesis was estimated by measuring L(14C)amino acid incorporation in trichloroacetic acid insoluble cell protein as previously described (11). Binding Experiments: Binding of 1251-labeled hCG and 1251-labeled PDP-hCG was carried out using freshly prepared Leydig cells by the method of Chang --. et al (12). Prior to binding, control and PDP-hCG samples were reduced with 20 mM dithiothreitol to release the reactive pyridine 2-thiol to determine the extent of derivitization (13) and remove the highly reactive group which reacts with cell surface proteins and produces artifactuallyhigh binding. Following the reduction, all hCG samples were reannealed by dialysis against PBS at 4°C for 24 hours.
RESULTS AND DISCUSSION The inactivation of free the
fragment
SPSP method
modification that
of
A into
in cells
the cytosol.
by diphtheria Fragment
we have previously
used (14).
free
groups
and it
to four
or more
hormone
to its
modification
the binding
of EF-2
amino
of three
ability
of this
radiolabeled
hCG with
be used which
would
SPDP in order
is
431
requires
A was therefore However, known
of the specific
to determine
give maximum derivatixation
toxin
this
from
coupled method
the
lysines
work
ratio
of hCGwith
to hCG by involves
the
of Puett
(15)
of hCG greatly
receptor. what
the release
Thus,
reduce
we titrated
of SPDP to hCG could minimal
loss
of binding
Vol.
133,
activity.
The results
not result with
BIOCHEMICAL
No. 2. 1985
in loss
of these
of hCG and these Once the
ratio
derivatization
not
are
of
hCG using mixture
bound
was first
while
the
retained
by virture
A with
the Sepharose
hCG-DTA of the
its
was then
mannose
fragment retained
containing
The free
with
Thus,
only
column.
diphtheria
Ratio
toxin
*Binding derivatized
A) was not
bound
to
the
the bound hCG-diphtheria
toxin
TO LEYDIG
40
1.0
97
a3
5.0
40
>I00
10.0
10
>I00
20.0
9
>lOO
50.0
10
>lOO
at 4°C for 1 hour.
54,074
dpm with
non-specific
"Based on release of pyridine 2-thiol (13). there was more than 1 mole of PDP incorporated incorporated for the 5O:l ratio.
432
fragment coupled
of toxin
to hCG
Control
affinity A chain
column. hybrid.
CELL
binding (nonbinding subtracted.
With ratios per mole
of of
is
of the protein
Molar % hCG derivatized**
96
was
were
The resulting
A bound
0.5
hCG)
of the
diphtheria
1, the majority
(X control)
was conducted
A chain,
hCG, because
fragment
Binding*
(SPDP:hCG)
column.
to
hCG was
as the A chain
to ConA whereas
Table 1 EFFECT OF SPDP MODIFICATION OF hCG ON BINDING Molar
free
10 mM adenine.
As shown in Figure
eluted
Uncoupled
site
as well
as maximum
The resultant
(8).
column.
A-Sepharose binds
conducted
A was coupled
as unreacted
A chain
diphtheria
Fragment
ofo-methylmannoside
fragment
reported
PBS containing
oligosaccharide,
not.
as well
of the NAD+ binding
to a Conconavalin
on the affinity
(unincorporated Addition
applied
A does
interaction
eluted
toxin
as well
did
80% derivatization
maximum binding
previously
hybrid,
reactions
in over
to a NAD-Sepharose
bound NAD+.
to hCG was subsequently eluent
applied
ratio
molar
1.
diphtheria
we have
COMMUNICATIONS
a I:1
In addition,
in Table
SPDP to hCG to give
methods
that
resulted
more
summarized
RESEARCH
indicated of hCG.
or
had been established,
derivatized reaction
binding
at 10 mg/ml
results
BIOPHYSICAL
experiments
of significant
hCG concentrations
AND
5:l or greater, hCG up to 5 moles
Vol.
133,
No.
2, 1985
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
.5
.4
x a
I!IO 50
83
20
,2
-i
1 70
so
30
I
I
I
80
90
loo
FRACTION
of
63,
65,
mercaptoethanol
there
is
upon
no
free
A chain
recution
hCG u and
FIGURE 2. (a) 20 ug 70; (e) 20 ul fraction e were not phoresis.
the
A chain
(10
ug)
b
the is
does
c
present
well
d
It
under (lane
can
our
is
presence be
seen
and in
fractions
Figure (b,c,d)
interesting
conditions
absence
(lane
to
note
a),
but
f).
f
e
the
eluted
(g,h,i).
stain
in As
gel.
or-methylmannoside
not
stain
column (3ml) was directly with PBS. The column was was then eluted with 0.5 M
examined
SDS-polyacrylamide
in
I3 subunits
a
1) were
67 (Figure
on a 14%
reduction,
non-reduced
and
I3
NUMBER
The fraction eluted from the NAD-Sepharose FIGURE 1. applied to the Con-A Sepharose column equilibrated washed with PBS until A 280 = 0 (insert). The hybrid a-methylmannoside in PBS.
Frac:tions
40
9
h
I
i
SDS polyacrylamide gel electrophoresis of samples from the Con-A column. hCG; (b) 40 pl fraction 58; (c) 40 ul fraction 60; (d) 40 ul fraction ug nicked diphtheria toxin; (f) 20 pg hCG; (g) 40 pl fraction 58; (h) 40 diphtheria toxin. Lanes a60; (i) 40 u1 fraction 70; (j) 20 pg nicked reduced, lanes E-j were reduced with 2-mercaptoethanol prior to electro-
433
2, but that upon
Vol.
133,
No. 2, 1985
BIOCHEMICAL
-+ -It-
AND
Dipbthcria KG-S-S-D14
1 IO-”
I lo-‘0
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
Toxin
I 10-g
‘X-X
I 10-8
10-7
[TOXIN],
10-S
M
FIGURE 3. 1 ml of freshly isolated Leydig cells 105/ml in RPMI-1640 with the indicated concentrations of toxin or hybrid for 6 hours. acid mixture was added and the incubation continued for an additional incubations were stopped with the addition of 100 pl of 100% TCA and Controls incorporated 43,600 + 1540 cpm. content determined. average of three incubations.
Fractions results
shown
with
intact
are
resistant
is
a dose not
the
orders
10-6
effects
of
the
hybrid.
As
can
magnitude
reported
and
no
lack
that
up to
of
had
concentrated
3 indicate
toxic
hybrid
toxin
dependent
manner
and
while
assayed
there
is
M, remembering toxin,
for
little
the
cells
hybrid
has hCGB
than
the
K562,
Molt-4,
or
mouse
In
addition,
no
murine
Leydig
toxic
activity. or
that
the
be seen,
more
Typical toxicity
cells were an
seen
in
general
exquisitely
LD50
= 5 x 10-8~
chain-ricin
A chain
(11,141.
effect
on
hCG receptors.
diphtheria
was
able
which
to
inhibit
antibody the
paralleled
L cells
the ir
which
directed
toxic
activity
abi lity
to
were
towards of
the
inhibit
used either
hybrid
binding
in (data
shown). Based
-Ricin
on
these
A chain
previously hCG and the
pooled,
toxin
previously
controls or
the
several
The
hCG
figure
to to
we have
as
in
were
diphtheria
sensitive and
55-75
were treated [ l4C]-amino hour. The the radioactive Points are the
same
conjugate,
reported the
seed
results,
we using
(11,141, protein
gelonin
had
also
prepared
intact
hCG
an (16)
LD50
434
rather
= lo-9M.
exhibited
conditions.
two
other than The
an LD50
hCG the
hybrids.
13 subunit
conjugate = lo-gM
The alone
prepared when
assayed
hCG as
we
using under
Vol.
133,
The
above
of
the
of
monoclonal
for many
described
problems
its
Leydig
which
are
antibodies
receptor tumor
antigens
which
complexes
on
tumor
is cells
be
to
receptors
of
known
function.
deficient
in
binding
and/or
this
tumor
may
and
currently
For
this have
known
to
which
are
in
toxins.
cell
extended
here,
in
model
be
the
receptor no
and
model
to
include
Studies
for
overcoming hybrids
is
a known
of
In
unlike
addition,
and
other
study
the
antigen-antibody More
underway further
specific
function,
many
such
many composed
highly
internalize.
currently
internalization
of hCG
unlike to
in
function.
studies
are
study
has
known
fail
COMMUNICATIONS
be useful
instance,
internalized
shed
RESEARCH
of macromolecules,
reported
pathway
BIOPHYSICAL
encountered
on receptormediateduptake can
tumor
currently
Leydig
complex
AND
cell
coupled
on the
hCG-receptor
studies
BIOCHEMICAL
No. 2, 1985
the
generally,
hybrid
unique
proteins
cell
to
isolate
of
the
surface mutants
endocytotic
system.
REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16.
Neaves, W. B. (1973) J. Natl. Cancer Inst., 0, 1069-1073. Ascoli, M. and Puett, D. (1978). Proc. Natl. Acad. Sci. USA, 75, 99-102. Greenwood, F. C., Hunter, W. M., and Glover, J. S. (1963) Biochem. J., E, 114-123. Bellisario, R. and Bahl, 0. P. (1975) J. Biol Chem. 250, 3837-3844. Waddell, W. J. (1956) J. Lab. Clin. Med., 48, 311-314. (1970) Nature, 227, 680-685. Laemmli, V. K. O’Farrell, P., Goodman, H., and O’Farrell, P. (1977) Cell, 12, 1133-1142. Chung, D. N. and Collier, R. J. (1977) Biochem. Biophys. Acta, 483, 248-257. Oeltmann, T. N. and Forbes, J. T. (1981) Arch. Biochem. Biophys., 209, 362-370. Wallace, E. F., and Wofsy, L. (19801, Fed. Proc. Fed. Amer. Martinez, O., Sot. Exp. Biol., 21, 719. Oeltmann, T.N. and Heath, E. C. (1979) J. Biol. Chem., 254, 1028-1032. Daxard, A. and Neville, D. M., Jr. (1977) J. xl. Chem., 252, Chang, T., 1515-1522. Stuchbury , T. , Shipton, M. and Norris, R. (1975) Biochem. .I., 151, 417-432. Oeltmann, T. N. and Heath, E. C. (1979) J. Biol. Chem., 254, 1022-1028. Puett, D. J., personal communication. Stirpe, F., Olsnes, S. and Pihl, A. (1980) J. Biol. Chem., 255, 6947-6955.
435